ADMA Biologics ADMA Market capitalization

Market capitalization at other companies

AbCellera Biologics Inc.ABCL

$2.4B+118%

Lifecore Biomedical, Inc.LFCR

$164.67M-42.2%

AnaptysBio, Inc.ANAB

$1.59B+180%

Absci CorporationABSI

$459.06M+43.6%

Avalo TherapeuticsAVTX

$971.41M+1,712%

Apogee Therapeutics, Inc.APGE

$6.28B+189%

FAQ

What is ADMA Biologics's market capitalization?

ADMA Biologics (ADMA) reported market capitalization of $1.94B in Q2 2026.

How has ADMA Biologics's market capitalization changed year-over-year?

ADMA Biologics's market capitalization decreased by 54.5% year-over-year, from $4.26B to $1.94B.

What is the long-term trend for ADMA Biologics's market capitalization?

Over 5 years (2020 to 2025), ADMA Biologics's market capitalization has grown at a 62.6% compound annual growth rate (CAGR), from $381.84M to $4.34B.

What does market capitalization mean?

The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.